Arcadia Biosciences (RKDA) Gross Profit (2014 - 2026)

Arcadia Biosciences (RKDA) has 12 years of Gross Profit data on file, last reported at $192000.0 in Q4 2025.

• Quarterly Gross Profit fell 50.64% year-over-year to $192000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (down 15.55% YoY) and the FY2025 annual result came in at $1.8 million, down 15.47% from the prior year.
• Gross Profit declined to $192000.0 in Q4 2025, from $418000.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $835.4 million in Q2 2021 to a low of -$6.7 million in Q4 2022.
• A 5-year average of $41.8 million and a median of $492500.0 in 2023 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2021 — Gross Profit jumped 69199.5% — and 2022, when it tumbled 1329.3%.
• Tracing RKDA's Gross Profit over 5 years: stood at $546000.0 in 2021, then plunged by 1329.3% to -$6.7 million in 2022, then soared by 108.92% to $599000.0 in 2023, then plunged by 35.06% to $389000.0 in 2024, then tumbled by 50.64% to $192000.0 in 2025.
• The last three Gross Profit figures came in at $192000.0 (Q4 2025), $418000.0 (Q3 2025), and $631000.0 (Q2 2025), per Business Quant data.